CAAP® – Building Companies
Entrepreneurship Program
Description:
OBIO® Capital Access Advisory Program (CAAP®), a 9-month structured program for health science companies is designed to operate downstream from existing entrepreneurship programs and focuses on accelerating technology commercialization, working towards Series A financing and strategic partnerships. CAAP® covers three fundamental business themes:
1. Business strategic planning & increasing the ROI for investors;
2. Advanced fundraising strategies & financial modeling;
3. Closing an investment round.
Comments on Funding:
No funding provided.
Rolling deadline
Eligibility:
Applicants must be:
1. health science companies;
2. starting to raise Series A financing in Q4 2023 to 2024 timeframe.
Application Steps:
No specific steps have been identified.
Documentation Needed:
No specific documentation has been identified.
Other Things to Note:
For further details, please contact:
Jack Lee
Director, Technology Commercialization
416.848.6839, ext. 102
About the author
Maurice
